Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
|---|---|---|---|---|---|
| C1306759 | Eosinophilic disorder | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0027651 | Neoplasms | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0524851 | Neurodegenerative Disorders | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C1956346 | Coronary Artery Disease | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C3714636 | Pneumonitis | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0036341 | Schizophrenia | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0023895 | Liver diseases | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0015397 | Disorder of eye | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0010054 | Coronary Arteriosclerosis | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0023467 | Leukemia, Myelocytic, Acute | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0032285 | Pneumonia | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0020538 | Hypertensive disease | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0017638 | Glioma | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0010068 | Coronary heart disease | PLA2G5 | 5322 | phospholipase A2 group V | P39877 |
| C0010072 | Coronary Thrombosis | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
| C0376358 | Malignant neoplasm of prostate | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
| C0242422 | Parkinsonian Disorders | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
| C0010068 | Coronary heart disease | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
| C0014038 | Encephalitis | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
| C0006826 | Malignant Neoplasms | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
| C0476089 | Endometrial Carcinoma | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
| C0027051 | Myocardial Infarction | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
| C2931845 | Neurodegeneration with brain iron accumulation (NBIA) | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
| C0011847 | Diabetes | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
| C0010054 | Coronary Arteriosclerosis | PLA2G6 | 8398 | phospholipase A2 group VI | O60733 |
